MLB Drug Policy: Why Contracts Are the Real Problem (Jurickson Profar Case Study) (2026)

In the world of Major League Baseball (MLB), the issue of performance-enhancing drugs (PEDs) has once again come to the forefront with the recent suspension of Jurickson Profar. This incident raises important questions about the league's drug policy and the implications it has for players, teams, and the integrity of the sport itself.

The Profar Incident: A Case Study

Profar, a talented baseball player, has been suspended for a second time in a year for violating the league's drug policy. This violation carries a hefty penalty: a full-season suspension and the loss of his $15 million salary for 2026. However, the story doesn't end there. Profar's contract with the Atlanta Braves extends beyond this season, and he is still set to receive his full salary of $15 million in 2027, regardless of his performance or even if he is no longer with the team.

This scenario highlights a critical issue with MLB's current drug policy and contract structure. While Profar's mistakes have cost him financially, the long-term financial implications are minimal compared to the potential lifetime earnings of a professional athlete.

The Bigger Picture: MLB's Drug Policy and Contracts

MLB's drug policy, which includes random testing and penalties for violations, is designed to deter players from using PEDs. However, the current system seems to have loopholes that players can exploit. The penalty structure, with its three-strike system (80-game ban for the first offense, full-season ban for the second, and lifetime ban for the third), may not be enough to deter players who stand to gain significantly from using PEDs.

The problem lies in the guaranteed nature of MLB contracts. Even if a player is suspended or performs poorly due to drug use, they are still entitled to their full salary, as long as they haven't been caught three times. This creates an incentive for players to take the risk, especially if they believe they can get away with it or if the potential gains outweigh the potential losses.

A Veteran's Perspective

A conversation with a veteran player sheds light on this issue. When asked about the risks of PEDs, the player laughed, suggesting that the real risk for many players is not getting caught. The potential rewards, such as elevated stats and big multi-year deals, are often seen as worth the risk of getting caught once or twice.

Atlanta Braves' Dilemma

The Atlanta Braves, who signed Profar to a three-year, $42 million contract, find themselves in a tricky situation. Profar's deal, which was met with skepticism at the time, could now be considered one of the worst free-agent contracts in history. However, the Braves had no way of knowing about Profar's drug use before signing him, and they are now powerless to void the contract despite his repeated violations.

The Need for Change

The current penalty system, while collectively bargained, may need to be reevaluated. Proposals to modify the rules, such as allowing teams to void contracts or renegotiate terms for players with drug violations, have been declined by the players' association.

The question arises: How can the league effectively deter players from using PEDs if the potential financial gains are so significant?

Player Perspectives

Interestingly, when the author reached out to current and former players for their opinions, there was no pushback. One player commented, "I don't condone any of this, but the way the system is set up, it's not hard to see how it happens."

Conclusion: A Call for Action

The Profar incident serves as a stark reminder that MLB's drug policy and contract structure need to be reexamined. While the sport has made progress since the "juiced" era of the 1990s and early 2000s, more can be done to ensure the integrity of the game.

The current system seems to prioritize player rights over the integrity of the sport. It's time to consider whether the penalties fit the crimes and whether there are ways to make the consequences more severe for repeat offenders.

As we move forward, the discussion around MLB's drug policy and contract structure will undoubtedly continue, with the hope of finding a balance that protects the rights of players while also maintaining the integrity and fairness of the game.

MLB Drug Policy: Why Contracts Are the Real Problem (Jurickson Profar Case Study) (2026)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Sen. Emmett Berge

Last Updated:

Views: 6145

Rating: 5 / 5 (80 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Sen. Emmett Berge

Birthday: 1993-06-17

Address: 787 Elvis Divide, Port Brice, OH 24507-6802

Phone: +9779049645255

Job: Senior Healthcare Specialist

Hobby: Cycling, Model building, Kitesurfing, Origami, Lapidary, Dance, Basketball

Introduction: My name is Sen. Emmett Berge, I am a funny, vast, charming, courageous, enthusiastic, jolly, famous person who loves writing and wants to share my knowledge and understanding with you.